Management of acute variceal bleeding
Upcoming SlideShare
Loading in...5
×
 

Management of acute variceal bleeding

on

  • 1,366 views

by hidayat at drhidayat.com

by hidayat at drhidayat.com

Statistics

Views

Total Views
1,366
Slideshare-icon Views on SlideShare
1,366
Embed Views
0

Actions

Likes
1
Downloads
75
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Decompensated liver cirrhosisCompensated liver cirrhosis
  • Add in prepare for blood transfusion if haemodynamic unstable.
  • Why antibiotic prophylaxis?

Management of acute variceal bleeding Management of acute variceal bleeding Presentation Transcript

  • Clinical Practice Guideline, May 2004
  •  10-30% of upper gastrointestinalhaemorrhage is a major cause of death in patients withcirrhosis. The aetiology of cirrhosis in Malaysia ismainly due to hepatitis B or alcohol In alcoholic liver disease, continuedabstinence from alcohol may result in adecreasing in size or even disappearance ofvarices.
  • • Severe consequence of portal hypertension secondaryto cirrhosis• Core symptoms co-exist with other emotional,behavioral & learning disordersDefinitionCo-morbidities• varies from 24-81% in oesophageal varices in patientswith cirrhosis• 60% of decompensated cirrhosis and 30% ofcompensated cirrhosis patientsPrevalenceClassification
  • Japanese US VATrial PaquetAbsent Absent Absent AbsentGrade 1: small, straight varices notdisappearing with insufflationSmall < 5 mm IGrade 2: medium varices occupyingless than one third of the lumenMedium 5-9 mm IIGrade 3: large varices occupyingmore than one third of the lumenLarge >9 mm IIIGiant IV
  • Increaseresistance toportal flowIncrease portalpressureVaricesVaricealgrowthDecreasearteriolarresistanceIncrease portalblood inflowCirrhosis
  •  Severity of the liver dysfunction Size of the varices (large greater thansmall) Presence of endoscopic red wale signs. Hepatic venous pressure gradient (HVPG)- ---- variceal bleeding will not occur if theHVPG is below 12mmHg.
  • ManagementActivebleedingepisodePreventionofrebleedingProphylacticmeasure toprevent the firsthaemorrhage
  •  Non-selective ß-adrenergic antagonists such aspropranolol and nadolol.- Propranolol 20mg bd titrated to achieve a 25%decrement in resting pulse rate or a pulse rateof 55-60 bpm) Screening endoscopy 1-2 yearly from the onsetof diagnosis of liver cirrhosis
  •  General Management:IV access and fluid resuscitationPrepare for blood transfusion if haemodynamicunstableCorrection of coagulopathy and thrombocytopeniaIntubation if severe uncontrollable bleeding,encephalopathic, inability to maintain O2 saturationadequately and to prevent aspiration
  • Specific therapy: Pharmacological therapy with vasoactive drugs to arrestthe bleeding (vasopressin/its analogue, somatostatin/itsanalogue)a) IV Terlipressin 2 mg stat bolus and 1 mg QID for 2-5days or;b) IV Somatostatin 250 mcg bolus followed with 250mcq/h infusion for 2-5 days or;c) IV bolus Octreotide 50 mcg stat followed with IVinfusion 50 mcg/h for 2-5 days
  • GenericnameTime tomaximumeffectDuration ofactionHalf -lifeSomatostatinTerlipressin 6 hourOctretideTerlipressin was not inferior to octreotide in itseffi cacy for controlling variceal bleed.
  •  Endoscopic Sclerotherapy or Endoscopicbanding or Adrenaline injection If bleeding uncontrolled a Minnesota tube orSangstaken-Blakemore tube is used.
  • a) Non-selective ß-adrenergic antagonists such aspropranolol and nadololb) Endoscopic sclerotherapy every 10-14 days untilthe varices are obliterated (5-6 sessions)orendoscopic variceal bandingc) Combination of pharmacological and endoscopicmanagement may be consideredd) Transjugular Intrahepatic Portosystemic Shunts(TIPSS)e) Surgical therapy (selective shunts ordevascularisation procedures)
  •  Antibiotic prophylaxis in patients with cirrhosis Antibiotic treatment should be continued for 7days Norfloxacin 400mg bd OR Ciprofloxacin 500mg bd or IV 200mg bd OR Third generation cephalosporins (e.g.Ceftriaxone 1g daily)
  •  Terlipressin vs. Octreotide in Bleeding EsophagealVarices as an AdjuvantTherapy With Endoscopic BandLigation:A Randomized Double-Blind Placebo-ControlledTrial